Vivos (RDGL) Non-Current Assets (2010 - 2025)

Vivos (RDGL) posted Non-Current Assets of $216514.0 for Q4 2025, up 32263.83% sequentially from $669.0 in Q3 2018.

Vivos (RDGL) Non-Current Assets (2010 - 2025) Analysis & Trends

Vivos has reported Non-Current Assets for 10 years, with the latest figure at $216514.0 in Q4 2025.

Quarterly Non-Current Assets changed N/A year-over-year to $216514.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $216514.0 (changed N/A YoY) and the FY2025 annual result came in at $216514.0, changed N/A from the prior year.
Non-Current Assets advanced to $216514.0 in Q4 2025 per RDGL's latest filing, from $669.0 in the prior quarter.
Over five years, Non-Current Assets peaked at $216514.0 in Q4 2025 and troughed at $216514.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Assets (Qtr)
1	Abbott Laboratories	200.51 Bn	194.91 Bn	7.27 Bn	84.70 Bn
2	Stryker	129.96 Bn	126.48 Bn	4.50 Bn	33.51 Bn
3	Medtronic	120.18 Bn	110.96 Bn	6.41 Bn	68.24 Bn
4	Boston Scientific	74.28 Bn	73.74 Bn	3.85 Bn	37.24 Bn
5	Edwards Lifesciences	52.75 Bn	48.50 Bn	1.35 Bn	7.05 Bn
6	Dexcom	34.67 Bn	32.73 Bn	830.00 Mn	2.37 Bn
7	GE HealthCare Technologies	34.23 Bn	32.12 Bn	2.18 Bn	26.75 Bn
8	Koninklijke Philips	26.46 Bn	23.14 Bn	4.55 Bn	20.19 Bn
9	Steris	23.30 Bn	22.82 Bn	684.20 Mn	8.29 Bn
10	Vivos	24.90 Mn	23.34 Mn	-3,105.00	216,514.00

Download Data